Josh Weinger is an associate in the firm’s Litigation Department and a member of its Intellectual Property Group. Mr. Weinger focuses his practice on patent matters, with a concentration in the areas of biotechnology and pharmaceuticals. Mr. Weinger is a contributor to the firm’s Big Molecule Watch blog which tracks developments in the biosimilars space. He joined Goodwin in 2014.
Prior to law school, Mr. Weinger was a postdoctoral fellow at The Rockefeller University in the Laboratory of Chemistry and Cell Biology. During law school he worked as an intern at the U.S. Attorney’s Office for the District of Massachusetts.
While attending law school, Mr. Weinger was the lead submissions editor for the Yale Journal of Law and Technology, a fellow in the Yale Information Society Project, and a Knight Law and Media Scholar.
Prior to law school, Mr. Weinger was a National Science Foundation Graduate Research Fellow and received a Ruth L. Kirschstein National Research Service Award from the National Institutes of Health.
Mr. Weinger is the author of numerous articles in peer-reviewed journals including Nature, Nature Structural and Molecular Biology, The Journal of the American Chemical Society, and The Journal of Cell Biology.
Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.
客户信赖我们世界一流的咨询服务，希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题，涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息，请与我们联系。